Clinical trial
Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers
NCT00607347 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers
- Lead sponsor
- University of Florida
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 29, 2008
- Completion date
- June 30, 2009
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.